Ngô Charlotte, Chéreau Christiane, Nicco Carole, Weill Bernard, Chapron Charles, Batteux Frédéric
Faculté de Médecine, Service de Gynécologie Obstétrique II et Médecine de la Reproduction, AP-HP Hôpital Cochin, Paris, France.
Am J Pathol. 2009 Jul;175(1):225-34. doi: 10.2353/ajpath.2009.080804. Epub 2009 Jun 4.
Endometriosis is associated with chronic inflammation, and reactive oxygen species (ROS) are proinflammatory mediators that modulate cell proliferation. We have investigated whether the dysregulation of ROS production in endometriotic cells correlates with a pro-proliferative phenotype and can explain the spreading of this disease. Stromal and epithelial cells were purified from ovarian endometrioma and eutopic endometrium from 14 patients with endometriosis to produce four primary cell lines from each patient. ROS production, detoxification pathways, cell proliferation, and mitogen-activated protein kinase pathway activation were studied and compared with epithelial and stromal cell lines from 14 patients without endometriosis. Modulation of the proliferation of endometriosis by N-acetyl-cysteine, danazol, and mifepristone was tested in vitro and in 28 nude mice implanted with endometriotic tissue of human origin. Endometriotic cells displayed higher endogenous oxidative stress with an increase in ROS production, alterations in ROS detoxification pathways, and a drop in catalase levels, as observed for tumor cells. This increase in endogenous ROS correlated with increased cellular proliferation and activation of ERK1/2. These phenomena were abrogated by the antioxidant molecule N-acetyl-cysteine both in vitro and in a mouse model of endometriosis. Human endometriotic cells display activated pERK, enhanced ROS production, and proliferative capability. Our murine model shows that antioxidant molecules could be used as safe and efficient treatments for endometriosis.
子宫内膜异位症与慢性炎症相关,活性氧(ROS)是调节细胞增殖的促炎介质。我们研究了子宫内膜异位症细胞中ROS产生的失调是否与促增殖表型相关,以及是否可以解释这种疾病的扩散。从14例子宫内膜异位症患者的卵巢子宫内膜异位囊肿和在位内膜中纯化基质细胞和上皮细胞,为每位患者建立四种原代细胞系。研究了ROS产生、解毒途径、细胞增殖和丝裂原活化蛋白激酶途径激活情况,并与14例非子宫内膜异位症患者的上皮和基质细胞系进行比较。在体外和28只植入人源性子宫内膜异位组织的裸鼠中测试了N-乙酰半胱氨酸、达那唑和米非司酮对子宫内膜异位症增殖的调节作用。与肿瘤细胞一样,子宫内膜异位症细胞表现出更高的内源性氧化应激,ROS产生增加,ROS解毒途径改变,过氧化氢酶水平下降。内源性ROS的这种增加与细胞增殖增加和ERK1/2激活相关。抗氧化分子N-乙酰半胱氨酸在体外和子宫内膜异位症小鼠模型中均消除了这些现象。人子宫内膜异位症细胞表现出pERK激活、ROS产生增强和增殖能力。我们的小鼠模型表明,抗氧化分子可作为治疗子宫内膜异位症的安全有效药物。